Existing users please login

 

Home / Markets

Pre-Market Movers: Eurand N.V., Bebe

 
By Michael Goldstein
FOXBusiness
     

    Stock futures were pointing to a higher open as Wall Street waits on the release of consumer sentiment numbers due out later this morning. 

    Here are some of Friday’s early-morning movers. 

    Omnivision Technologies Inc. (OVTI

    While Omnivision, which manufacturers semiconductor image sensors, reported a first-quarter non-GAAP loss of 8 cents per share after the bell on Thursday, the stock was up 15.3% in Friday’s pre-markets after raising forward guidance above street expectations. 

    Eurand N.V. (EURX

    Specialty pharmaceutical maker Eurand announced the FDA has approved its new drug application for Zenpep for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis or other conditions. Shares were up 33.8% in pre-market trading.

     Marvell Technology Group Ltd. (MRVL

    Chipmaker Marvell released second-quarter results after the bell Thursday beating expectations with earnings per share excluding items of 18 cents. Analysts had been expecting earnings of 14 cents per share. The stock was up 7.4% in Friday’s pre-market trading.

     Bebe Stores Inc. (BEBE)

    Shares of retailer were down 10.2% in pre-market trading Friday after posting a fourth-quarter loss after the bell Thursday. The company reported a loss of 5 cents per share and revenue was down 24% from the same period last year. Analysts had been expecting earnings of 4 cents per share. 

    Novell Inc. (NOVL

    The software maker released third-quarter results after the bell Thursday reporting earnings per share excluding items of 7 cents per share in-line with analyst expectations. Revenue came in at $216 million, slightly below Street expectations of $217 million. Shares were down 3% in pre-market trading Friday 

    Micros Systems Inc. (MCRS

    While Micros Systems beat fourth-quarter expectations reporting non-GAAP earnings per share of 36 cents after the bell Thursday, the stock was down 3.5% in Friday’s pre-markets after analysts at Brean Murray, Carret & Co cut their rating to “hold” from “buy.”